SLE patients with mucocutaneous manifestations had significantly elevated anti-ficolin-1 (p = 0.038) autoantibodies, while those with musculoskeletal manifestations had reduced anti-ficolin-3 (p = 0.007) autoantibodies. The gene discussed is FCN1; the disease is systemic lupus erythematosus.